These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8615716)

  • 21. Optimal latent TB control methods.
    Ridzon R
    Int J Tuberc Lung Dis; 2005 Mar; 9(3):236. PubMed ID: 15786884
    [No Abstract]   [Full Text] [Related]  

  • 22. Isoniazid preventive therapy in areas of high isoniazid resistance.
    Moulding T
    Arch Intern Med; 1996 Mar; 156(6):685-6. PubMed ID: 8629885
    [No Abstract]   [Full Text] [Related]  

  • 23. [Chemoprophylaxis for children exposed to tuberculosis].
    Iwasaki T
    Kekkaku; 1993 Jan; 68(1):1-4. PubMed ID: 8437419
    [No Abstract]   [Full Text] [Related]  

  • 24. Tuberculosis preventive therapy in HIV-infected persons: feasibility issues in developing countries.
    Hawken MP; Muhindi DW
    Int J Tuberc Lung Dis; 1999 Aug; 3(8):646-50. PubMed ID: 10460096
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A trial of mass isoniazid preventive therapy for tuberculosis control.
    Churchyard GJ; Fielding KL; Grant AD
    N Engl J Med; 2014 Apr; 370(17):1662-3. PubMed ID: 24758626
    [No Abstract]   [Full Text] [Related]  

  • 26. [Prevention and treatment of pregnancy-complicated tuberculosis].
    Yue Y; Yang Q; Zhang S
    Zhonghua Fu Chan Ke Za Zhi; 1998 Feb; 33(2):119-21. PubMed ID: 10682431
    [No Abstract]   [Full Text] [Related]  

  • 27. Physician adherence to isoniazid preventive therapy guidelines for HIV-infected patients in Thailand.
    Hiransuthikul N; Hiransuthikul P; Nelson KE; Jirawisit M; Paewplot R; Kasak S
    Southeast Asian J Trop Med Public Health; 2005 Sep; 36(5):1208-15. PubMed ID: 16438147
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preventing latent tuberculosis among HIV-infected patients: efficacious and effective, yet inefficient?
    Rieder HL
    Clin Infect Dis; 2007 Jan; 44(1):103-4. PubMed ID: 17143824
    [No Abstract]   [Full Text] [Related]  

  • 29. A new tool for monitoring isoniazid preventive therapy.
    Eisenhut M
    Int J Tuberc Lung Dis; 2013 Mar; 17(3):424. PubMed ID: 23407235
    [No Abstract]   [Full Text] [Related]  

  • 30. Liver transplantation without isoniazid prophylaxis for recipients with a history of tuberculosis.
    Nagai S; Fujimoto Y; Taira K; Egawa H; Takada Y; Kiuchi T; Tanaka K
    Clin Transplant; 2007; 21(2):229-34. PubMed ID: 17425750
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Randomised controlled trial of isoniazid preventive therapy in South African adults with advanced HIV disease.
    Mohammed A; Myer L; Ehrlich R; Wood R; Cilliers F; Maartens G
    Int J Tuberc Lung Dis; 2007 Oct; 11(10):1114-20. PubMed ID: 17945069
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness of tuberculosis preventive therapy in gold miners.
    Yaqub F
    Lancet Respir Med; 2014 Mar; 2(3):181. PubMed ID: 24745052
    [No Abstract]   [Full Text] [Related]  

  • 33. Alternatives to INH chemoprophylaxis.
    Sane SV; Sane NS; Thakker SV
    Indian Pediatr; 1995 Aug; 32(8):935-7. PubMed ID: 8635847
    [No Abstract]   [Full Text] [Related]  

  • 34. Short-term tuberculosis prophylaxis is effective in persons with HIV.
    Gordin F
    Am Fam Physician; 1998 Sep; 58(4):948. PubMed ID: 9767729
    [No Abstract]   [Full Text] [Related]  

  • 35. New guidelines about latent tuberculosis infection in children and adolescents: a welcome advancement.
    Nelson LJ; Jereb JA; Castro KG
    Pediatrics; 2004 Oct; 114(4):1084-6. PubMed ID: 15466109
    [No Abstract]   [Full Text] [Related]  

  • 36. A randomised controlled trial of high-dose isoniazid adjuvant therapy for multidrug-resistant tuberculosis.
    Moulding T
    Int J Tuberc Lung Dis; 2008 Sep; 12(9):1102; author reply 1102. PubMed ID: 18713512
    [No Abstract]   [Full Text] [Related]  

  • 37. Isoniazid preventive therapy for people living with HIV: public health challenges and implementation issues.
    Aït-Khaled N; Alarcon E; Bissell K; Boillot F; Caminero JA; Chiang CY; Clevenbergh P; Dlodlo R; Enarson DA; Enarson P; Ferroussier O; Fujiwara PI; Harries AD; Heldal E; Hinderaker SG; Kim SJ; Lienhardt C; Rieder HL; Rusen ID; Trébucq A; Van Deun A; Wilson N
    Int J Tuberc Lung Dis; 2009 Aug; 13(8):927-35. PubMed ID: 19723371
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Isoniazid preventive therapy in human immunodeficiency virus-infected persons. Long-term effect on development of tuberculosis and survival.
    Moreno S; Miralles P; Diaz MD; Baraia J; Padilla B; Berenguer J; Alberdi JC
    Arch Intern Med; 1997 Aug 11-25; 157(15):1729-34. PubMed ID: 9250234
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Efficiency of preventive chemotherapy in children and adolescents from the bacterial isolation foci of tuberculous infection].
    Ovsiankina ES; Kasimtseva OV; Vasil'eva IA
    Probl Tuberk Bolezn Legk; 2006; (1):3-6. PubMed ID: 16512175
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of isoniazid prophylaxis on incidence of active tuberculosis among Thai HIV-infected individuals.
    Saenghirunvattana S
    J Med Assoc Thai; 1996 May; 79(5):285-7. PubMed ID: 8708519
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.